Remove 2024 Remove Community Remove Medical Specialty Remove Patient-Centered
article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog

Peter Marks at James Valentine ’s FDA Rare Disease Town Hall session at the DIA Annual Meeting last month (see Pink Sheet coverage here ), this Hub is intended to serve as the Center of Excellence that we in the rare disease community have been calling for its establishment over the last several years.

article thumbnail

Geriatric Medicine Board Meeting Summary | Spring 2025

ABIM

Ruiz first joined the Specialty Board as a member in 2021. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. Community Practice in ABIM Governance* Erica N.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

JD , whose terms on the Specialty Board end June 30, 2025. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. This is now being reviewed by the American Board of Medical Specialties, which oversees ABIM.